Download PDF
Thromb Haemost 1995; 74(01): 515-520
DOI: 10.1055/s-0038-1642731
Symposium
Clinical Coagulation Laboratory and Oral Anticoagulation Therapy Treatment
Schattauer GmbH Stuttgart

Quality Control and Oral Anticoagulation

F E Preston
Department of Haematology, Royal Hallamshire Hospital, Sheffield, UK
› Author Affiliations
Further Information

Publication History

Publication Date:
09 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Poller L, Thomson JM. The Manchester comparative reagent. In Human Blood Coagulation. Hemker HC, Loelinger EA. Veltkamp eds Springer; New York: 1969. pp 290-295
    Google Scholar
  • 2 Zucker S, Cathey MH, Sox PJ, Paul EC. Standardization of laboratory tests for controlling anticoagulant therapy. Am J Path 1970; 53: 348-354
    PubMedGoogle Scholar
  • 3 Bailey EL, Harper TA, Pinkerton PH. Therapeutic range of 1-stage prothrombin time in control of anticoagulant therapy. CMAJ 1971; 94
    PubMedGoogle Scholar
  • 4 Hirsh J, Deykin D, Poller L. “Therapeutic range” for oral anticoagulant therapy. Chest 1989; 2 Suppl llS-15S
    PubMedGoogle Scholar
  • 5 Poller L, Tabemer DA. Dosage and control of oral anticoagulants, an international survey. Br J Haem 1982; 51: 479-485
    CrossrefPubMedGoogle Scholar
  • 6 Wright IS, Beck DF, Marple CD. Myocardial infarction and its treatment with anticoagulants. Lancet 1954; 92-97
    PubMedGoogle Scholar
  • 7 Poller L. INR and the therapeutic range. Biologia and Clinica Haematologica 1987; 9: 203-213
    PubMedGoogle Scholar
  • 8 Lewis SM. Annotation Thromboplastin and oral anticoagulant control. B J Haem 1987; 66: 1-4
    PubMedGoogle Scholar
  • 9 van den Besselaar AMHP, Bertina RM. Hierarchy of reference thromboplastins. B J Haem 1994; 88: 223-224
    PubMedGoogle Scholar
  • 10 Kirkwood TBL. Calibration of reference thromboplastins and standardisation of the prothrombin time ratio. Thromb Haem 1983; 49: 238-244
    PubMedGoogle Scholar
  • 11 Kirkwood TBL, Lewis SM. Requirements for thromboplastins and plasmas used to control oral anticoagulant therapy. WHO Technical Report Series 1983; 687: 81-99
    PubMedGoogle Scholar
  • 12 Kitchen S, Walker ID, Woods TAL, Preston FE. Thomboplastin related differences in the determination of international normalised ratio: A cause for concern. Thromb Haemostas 1994; 72: 426-429
    PubMedGoogle Scholar
  • 13 Collins RC, Phillips WS, Makris M, Preston FE. 1995 to be submitted
    PubMed
  • 14 Poller L, Tabemer DA, Thomson JM, Morris J, Mibasham RF, Shinton NK. Effect of the choice of WHO international reference preparation for thromboplastin on INR. J Clin Path 1983; 46: 64-66
    PubMedGoogle Scholar
  • 15 van den Bessalaar AMHP, Lewis SM, Mannucci PM, Poller L. On behalf of the subcommittee. Status of present and candidate international reference preparations (IRP) of thromboplastin for the prothrombin time. Thromb Haemostas 1993; 69: 85
    PubMedGoogle Scholar
  • 16 Thomson JM, Tabemer DA, Poller L. Automation and prothrombin time: A United Kingdom field study of two widely used coagulo- meters. J Clin Path 1990; 43: 679-684
    CrossrefPubMedGoogle Scholar
  • 17 van den Besselaar AMHP, Bertina RM. Multi-center calibration of the secondary reference material for thromboplastin, rabbit, plain, coded, CRM149R. Thromb Haemostas 1991; 65: 263-267
    PubMedGoogle Scholar
  • 18 Loeliger EA, Lewis SM. Progress in laboratory control of oral anticoagulants. Lancet 1982; 2: 318-320
    PubMedGoogle Scholar
  • 19 Rosendaal FR, Cannegieter SC, van der Meer FJM, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemostas 1993; 69: 236-240
    PubMedGoogle Scholar
  • 20 Phillips WS, Collin RC, Makris M, Preston FE. To be submitted
    PubMed
  • 21 Poller L. The correction of coagulometer effects on international normalized ratios: a multicentre evaluation. Brit J Haem 1994; 86: 112-117
    CrossrefPubMedGoogle Scholar